Prospective Analysis: Relative Survival in Patients with Chronic Myeloid Leukemia in Chronic Phase in the Era of Tyrosine Kinase Inhibitors

BACKGROUND: Tyrosine kinase inhibitors (TKIs) improved overall survival (OS) in patients with chronic myeloid leukemia in chronic phase (CML-CP). The purpose of this study was to compare OS in patients with newly diagnosed CML-CP to that of general population. METHODS: Response and survival data in...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Lancet Haematol
Main Authors: Sasaki, Koji, Strom, Sara S., O’Brien, Susan, Jabbour, Elias, Ravandi, Farhad, Konopleva, Marina, Borthakur, Gautam, Pemmaraju, Naveen, Daver, Naval, Jain, Preetesh, Pierce, Sherry, Kantarjian, Hagop, Cortes, Jorge E.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4884053/
https://ncbi.nlm.nih.gov/pubmed/26688093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2352-3026(15)00048-4
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki